Job contacts
215144 contacts for the current filters
| ID | Name | Title | Phone | Confidence | Primary | Context | Job | Company | Created at | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6908954 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Manager, Drug Product, Commercial Manufacturing | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908952 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | rivacy Policy</a>. For additional information, please contact <a href=… | Manager, Commercial Executive Operations, Spain and Portugal | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908950 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Manager, Clinical Biomarker Operations | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908948 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Manager, AI Learning Enablement & Coaching | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908946 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Machine Learning Scientist II, Drug Discovery Analytics | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908944 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Human Resources Business Partner, Manager, Japan | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908942 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Global Development Lead (GDL), Clinical Development | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908940 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Food & Beverage Specialist II | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908938 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Portfolio Systems & Strategy Integration | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908936 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Head of Real-World Analytics and Progra… | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908934 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Head of Procurement | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908932 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Global Marketing, PDAC Cancer Strategy … | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908930 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Global Commercial Lead | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908928 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, GCP QA (Good Clinical Practice, Quality… | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908926 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Early Clinical Development | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908924 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Clinical Supply Chain | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908922 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Executive Director, Clinical Development | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908920 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, US Medical Affairs, PDAC | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908918 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, US Medical Affairs, NSCLC | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908916 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, US Lung Market Research | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908914 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, US GI Market Research | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908912 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, US GI Analytics | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908910 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, Strategic Sourcing and Supplier Management | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908908 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, Senior Corporate Counsel, Italy | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |
| 6908906 | — | — | privacy@revmed.com | — | — | 0.7 | Primary | a>.&nbsp;For additional information, please contact&nbsp;<a href=… | Director, Senior Corporate Counsel, Germany | Revolution Medicines | Nov. 15, 2026, 1:37 a.m. |